Pliant Therapeutics Ownership 2024 | Who Owns Pliant Therapeutics Now?
Institutional Ownership
11.64%
Insider Ownership
2.86%
Retail Ownership
85.50%
Institutional Holders
44.00
Pliant Therapeutics Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| DEEP TRACK CAPITAL, LP | 9.92% | 1.92% | 5,972,257 | 222,257 | 3.87% | 64,201,763 | Jun 30, 2024 |
| BLACKROCK INC. | 8.26% | 0.00% | 4,971,639 | 316,254 | 6.79% | 53,445,123 | Jun 30, 2024 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 7.65% | 0.01% | 4,602,323 | 643,235 | 16.25% | 49,476,000 | Jun 30, 2024 |
| FMR LLC | 6.50% | 0.00% | 3,911,759 | -34,738 | -0.88% | 42,051,408 | Jun 30, 2024 |
| VANGUARD GROUP INC | 5.71% | 0.00% | 3,437,160 | -41,195 | -1.18% | 36,949,470 | Jun 30, 2024 |
| FIRST LIGHT ASSET MANAGEMENT, LLC | 5.65% | 3.21% | 3,401,213 | -133,780 | -3.78% | 36,563,040 | Jun 30, 2024 |
| REDMILE GROUP, LLC | 5.33% | 2.09% | 3,209,591 | 112,371 | 3.63% | 34,503,103 | Jun 30, 2024 |
| BLUE OWL CAPITAL HOLDINGS LP | 4.99% | 8.98% | 3,004,199 | - | - | 32,295,139 | Jun 30, 2024 |
| GREAT POINT PARTNERS LLC | 4.38% | 5.43% | 2,636,864 | 785,000 | 42.39% | 28,346,288 | Jun 30, 2024 |
| LAURION CAPITAL MANAGEMENT LP | 4.15% | 0.32% | 2,498,920 | -975,824 | -28.08% | 26,863,390 | Jun 30, 2024 |
| TRV GP IV, LLC | 3.54% | 11.34% | 2,132,867 | - | - | 22,928,320 | Jun 30, 2024 |
| POLAR CAPITAL HOLDINGS PLC | 3.35% | 0.13% | 2,015,000 | - | - | 21,661,250 | Jun 30, 2024 |
| DEUTSCHE BANK AG\ | 2.54% | 0.01% | 1,526,164 | 40,371 | 2.72% | 16,406,263 | Jun 30, 2024 |
| STATE STREET CORP | 2.29% | 0.00% | 1,376,120 | 57,353 | 4.35% | 14,793,290,000 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.14% | 0.00% | 1,287,087 | 72,204 | 5.94% | 13,839,511 | Jun 30, 2024 |
| RA CAPITAL MANAGEMENT, L.P. | 2.13% | 0.18% | 1,281,000 | - | - | 13,770,750 | Jun 30, 2024 |
| PICTET ASSET MANAGEMENT HOLDING SA | 1.99% | 0.01% | 1,195,779 | -111,832 | -8.55% | 12,854,624 | Jun 30, 2024 |
| FRANKLIN RESOURCES INC | 1.70% | 0.00% | 1,024,991 | -511,859 | -33.31% | 11,018,648 | Jun 30, 2024 |
| CASDIN CAPITAL, LLC | 1.66% | 0.82% | 1,000,000 | - | - | 10,750,000 | Jun 30, 2024 |
| GRANAHAN INVESTMENT MANAGEMENT, LLC | 1.63% | 0.42% | 982,049 | -64,796 | -6.19% | 10,557,027 | Jun 30, 2024 |
Pliant Therapeutics's largest institutional shareholder is DEEP TRACK CAPITAL, LP, holding 9.92% of the company's total share outstanding, currently valued at $64.20M. The top 10 institutional shareholders own together 62.55% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| MASS GENERAL BRIGHAM, INC | 0.48% | 15.11% | 288,690 | - | - | 3,103,418 | Jun 30, 2024 |
| TRV GP IV, LLC | 3.54% | 11.34% | 2,132,867 | - | - | 22,928,320 | Jun 30, 2024 |
| BLUE OWL CAPITAL HOLDINGS LP | 4.99% | 8.98% | 3,004,199 | - | - | 32,295,139 | Jun 30, 2024 |
| GREAT POINT PARTNERS LLC | 4.38% | 5.43% | 2,636,864 | 785,000 | 42.39% | 28,346,288 | Jun 30, 2024 |
| FIRST LIGHT ASSET MANAGEMENT, LLC | 5.65% | 3.21% | 3,401,213 | -133,780 | -3.78% | 36,563,040 | Jun 30, 2024 |
| REDMILE GROUP, LLC | 5.33% | 2.09% | 3,209,591 | 112,371 | 3.63% | 34,503,103 | Jun 30, 2024 |
| DEEP TRACK CAPITAL, LP | 9.92% | 1.92% | 5,972,257 | 222,257 | 3.87% | 64,201,763 | Jun 30, 2024 |
| FERNWOOD INVESTMENT MANAGEMENT, LLC | 0.82% | 1.65% | 496,286 | 47,901 | 10.68% | 5,335,075 | Jun 30, 2024 |
| CHECKPOINT CAPITAL L.P. | 0.39% | 1.50% | 232,200 | 232,200 | 100.00% | 2,496,150 | Jun 30, 2024 |
| EXOME ASSET MANAGEMENT LLC | 0.21% | 1.16% | 124,000 | 124,000 | 100.00% | 1,333,000 | Jun 30, 2024 |
| CASDIN CAPITAL, LLC | 1.66% | 0.82% | 1,000,000 | - | - | 10,750,000 | Jun 30, 2024 |
| BOND & DEVICK FINANCIAL NETWORK, INC. | 0.17% | 0.58% | 100,160 | - | - | 1,076,720 | Jun 30, 2024 |
| HIGHMARK WEALTH MANAGEMENT LLC | 0.11% | 0.44% | 67,500 | 25,000 | 58.82% | 725,625 | Jun 30, 2024 |
| GRANAHAN INVESTMENT MANAGEMENT, LLC | 1.63% | 0.42% | 982,049 | -64,796 | -6.19% | 10,557,027 | Jun 30, 2024 |
| ACUTA CAPITAL PARTNERS, LLC | 0.08% | 0.42% | 46,200 | 46,200 | 100.00% | 496,650 | Jun 30, 2024 |
| SPHERA FUNDS MANAGEMENT LTD. | 0.43% | 0.38% | 258,554 | - | - | 2,779,456 | Jun 30, 2024 |
| LAURION CAPITAL MANAGEMENT LP | 4.15% | 0.32% | 2,498,920 | -975,824 | -28.08% | 26,863,390 | Jun 30, 2024 |
| HARBOURVEST PARTNERS LLC | 0.08% | 0.28% | 49,434 | - | - | 531,416 | Jun 30, 2024 |
| RA CAPITAL MANAGEMENT, L.P. | 2.13% | 0.18% | 1,281,000 | - | - | 13,770,750 | Jun 30, 2024 |
| POLAR CAPITAL HOLDINGS PLC | 3.35% | 0.13% | 2,015,000 | - | - | 21,661,250 | Jun 30, 2024 |
The largest Pliant Therapeutics shareholder by % of total assets is MASS GENERAL BRIGHAM, INC. The company owns 288.69K shares of Pliant Therapeutics (PLRX), representing 15.11% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| GREAT POINT PARTNERS LLC | 4.38% | 5.43% | 2,636,864 | 785,000 | 42.39% | 28,346,288 | Jun 30, 2024 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 7.65% | 0.01% | 4,602,323 | 643,235 | 16.25% | 49,476,000 | Jun 30, 2024 |
| BLACKROCK INC. | 8.26% | 0.00% | 4,971,639 | 316,254 | 6.79% | 53,445,123 | Jun 30, 2024 |
| MORGAN STANLEY | 1.12% | 0.00% | 673,847 | 289,745 | 75.43% | 7,243,857 | Jun 30, 2024 |
| CANDRIAM S.C.A. | 1.38% | 0.05% | 833,216 | 285,216 | 52.05% | 8,956,654 | Jun 30, 2024 |
| CHECKPOINT CAPITAL L.P. | 0.39% | 1.50% | 232,200 | 232,200 | 100.00% | 2,496,150 | Jun 30, 2024 |
| DEEP TRACK CAPITAL, LP | 9.92% | 1.92% | 5,972,257 | 222,257 | 3.87% | 64,201,763 | Jun 30, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | 0.42% | 0.00% | 253,369 | 177,469 | 233.82% | 2,723,717 | Jun 30, 2024 |
| TREXQUANT INVESTMENT LP | 0.26% | 0.03% | 158,700 | 158,700 | 100.00% | 1,706,025 | Jun 30, 2024 |
| TWO SIGMA INVESTMENTS, LP | 0.41% | 0.01% | 245,572 | 138,548 | 129.46% | 2,639,899 | Jun 30, 2024 |
| RICE HALL JAMES & ASSOCIATES, LLC | 0.21% | 0.08% | 127,634 | 127,634 | 100.00% | 1,372,066 | Jun 30, 2024 |
| EXOME ASSET MANAGEMENT LLC | 0.21% | 1.16% | 124,000 | 124,000 | 100.00% | 1,333,000 | Jun 30, 2024 |
| REDMILE GROUP, LLC | 5.33% | 2.09% | 3,209,591 | 112,371 | 3.63% | 34,503,103 | Jun 30, 2024 |
| BANK OF AMERICA CORP /DE/ | 1.00% | 0.00% | 604,245 | 106,431 | 21.38% | 6,495,634 | Jun 30, 2024 |
| SQUAREPOINT OPS LLC | 0.13% | 0.00% | 80,475 | 80,475 | 100.00% | 865,106 | Jun 30, 2024 |
| UBS OCONNOR LLC | 0.13% | 0.05% | 77,000 | 77,000 | 100.00% | 827,750 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.14% | 0.00% | 1,287,087 | 72,204 | 5.94% | 13,839,511 | Jun 30, 2024 |
| HENNION & WALSH ASSET MANAGEMENT, INC. | 0.11% | 0.04% | 68,289 | 68,289 | 100.00% | 734,107 | Jun 30, 2024 |
| PDT PARTNERS, LLC | 0.11% | 0.06% | 63,352 | 63,352 | 100.00% | 681,034 | Jun 30, 2024 |
| BARCLAYS PLC | 0.10% | 0.00% | 60,000 | 60,000 | 100.00% | 645,000 | Jun 30, 2024 |
As of Jun 30 2024, Pliant Therapeutics's largest institutional buyer is GREAT POINT PARTNERS LLC. The company purchased 785.00K stocks of PLRX, valued at $28.35M.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| CAPITAL INTERNATIONAL INVESTORS | 0.37% | 0.00% | 224,997 | -1,152,330 | -83.66% | 2,418,718 | Jun 30, 2024 |
| LAURION CAPITAL MANAGEMENT LP | 4.15% | 0.32% | 2,498,920 | -975,824 | -28.08% | 26,863,390 | Jun 30, 2024 |
| FRANKLIN RESOURCES INC | 1.70% | 0.00% | 1,024,991 | -511,859 | -33.31% | 11,018,648 | Jun 30, 2024 |
| AMERIPRISE FINANCIAL INC | - | - | - | -371,126 | -100.00% | - | Jun 30, 2024 |
| GOLDMAN SACHS GROUP INC | 0.35% | 0.00% | 213,238 | -289,333 | -57.57% | 2,292,308 | Jun 30, 2024 |
| UBS GROUP AG | 0.25% | 0.00% | 152,202 | -212,862 | -58.31% | 1,636,171 | Jun 30, 2024 |
| CUTTER CAPITAL MANAGEMENT, LP | - | - | - | -194,119 | -100.00% | - | Jun 30, 2024 |
| SILVERARC CAPITAL MANAGEMENT, LLC | - | - | - | -183,392 | -100.00% | - | Jun 30, 2024 |
| FIRST LIGHT ASSET MANAGEMENT, LLC | 5.65% | 3.21% | 3,401,213 | -133,780 | -3.78% | 36,563,040 | Jun 30, 2024 |
| MARSHALL WACE, LLP | - | - | - | -130,935 | -100.00% | - | Jun 30, 2024 |
| PICTET ASSET MANAGEMENT HOLDING SA | 1.99% | 0.01% | 1,195,779 | -111,832 | -8.55% | 12,854,624 | Jun 30, 2024 |
| FRED ALGER MANAGEMENT, LLC | - | - | - | -97,082 | -100.00% | - | Jun 30, 2024 |
| GRANAHAN INVESTMENT MANAGEMENT, LLC | 1.63% | 0.42% | 982,049 | -64,796 | -6.19% | 10,557,027 | Jun 30, 2024 |
| ATOM INVESTORS LP | - | - | - | -58,064 | -100.00% | - | Jun 30, 2024 |
| ARTIA GLOBAL PARTNERS LP | 0.08% | 0.10% | 50,000 | -50,000 | -50.00% | 537,500 | Jun 30, 2024 |
| RUSSELL INVESTMENTS GROUP, LTD. | 0.00% | - | 344 | -46,270 | -99.26% | 3,698 | Jun 30, 2024 |
| VANGUARD GROUP INC | 5.71% | 0.00% | 3,437,160 | -41,195 | -1.18% | 36,949,470 | Jun 30, 2024 |
| NEW YORK STATE COMMON RETIREMENT FUND | 0.04% | 0.00% | 22,282 | -37,388 | -62.66% | 240,000 | Jun 30, 2024 |
| FMR LLC | 6.50% | 0.00% | 3,911,759 | -34,738 | -0.88% | 42,051,408 | Jun 30, 2024 |
| HIGHVISTA STRATEGIES LLC | - | - | - | -34,039 | -100.00% | - | Jun 30, 2024 |
As of Jun 30 2024, Pliant Therapeutics's biggest institutional seller is CAPITAL INTERNATIONAL INVESTORS. The company sold -1.15M shares of PLRX, valued at $2.42M.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| CHECKPOINT CAPITAL L.P. | 0.39% | 1.50% | 232,200 | 232,200 | 100.00% | 2,496,150 | Jun 30, 2024 |
| TREXQUANT INVESTMENT LP | 0.26% | 0.03% | 158,700 | 158,700 | 100.00% | 1,706,025 | Jun 30, 2024 |
| RICE HALL JAMES & ASSOCIATES, LLC | 0.21% | 0.08% | 127,634 | 127,634 | 100.00% | 1,372,066 | Jun 30, 2024 |
| SQUAREPOINT OPS LLC | 0.13% | 0.00% | 80,475 | 80,475 | 100.00% | 865,106 | Jun 30, 2024 |
| UBS OCONNOR LLC | 0.13% | 0.05% | 77,000 | 77,000 | 100.00% | 827,750 | Jun 30, 2024 |
| HENNION & WALSH ASSET MANAGEMENT, INC. | 0.11% | 0.04% | 68,289 | 68,289 | 100.00% | 734,107 | Jun 30, 2024 |
| PDT PARTNERS, LLC | 0.11% | 0.06% | 63,352 | 63,352 | 100.00% | 681,034 | Jun 30, 2024 |
| BARCLAYS PLC | 0.10% | 0.00% | 60,000 | 60,000 | 100.00% | 645,000 | Jun 30, 2024 |
| VERITION FUND MANAGEMENT LLC | 0.09% | 0.00% | 56,501 | 56,501 | 100.00% | 607,386 | Jun 30, 2024 |
| ACUTA CAPITAL PARTNERS, LLC | 0.08% | 0.42% | 46,200 | 46,200 | 100.00% | 496,650 | Jun 30, 2024 |
| COREBRIDGE FINANCIAL, INC. | 0.05% | 0.00% | 30,655 | 30,655 | 100.00% | 329,541 | Jun 30, 2024 |
| MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 0.05% | 0.00% | 29,286 | 29,286 | 100.00% | 314,825 | Jun 30, 2024 |
| DYNAMIC TECHNOLOGY LAB PRIVATE LTD | 0.03% | 0.02% | 17,487 | 17,487 | 100.00% | 188,000 | Jun 30, 2024 |
| GRAHAM CAPITAL MANAGEMENT, L.P. | 0.03% | 0.00% | 15,022 | 15,022 | 100.00% | 161,487 | Jun 30, 2024 |
| ATRIA WEALTH SOLUTIONS, INC. | 0.02% | 0.00% | 11,715 | 11,715 | 100.00% | 125,936 | Jun 30, 2024 |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 0.02% | 0.00% | 11,678 | 11,678 | 100.00% | 125,539 | Jun 30, 2024 |
| D. E. SHAW & CO., INC. | 0.02% | 0.00% | 10,679 | 10,679 | 100.00% | 114,799 | Jun 30, 2024 |
| ADAR1 CAPITAL MANAGEMENT, LLC | 0.02% | 0.02% | 10,000 | 10,000 | 100.00% | 107,500 | Jun 30, 2024 |
| CLEAR STREET MARKETS LLC | 0.01% | 0.01% | 5,532 | 5,532 | 100.00% | 59,000 | Jun 30, 2024 |
| QUARRY LP | 0.00% | 0.00% | 104 | 104 | 100.00% | 1,118 | Jun 30, 2024 |
| SMARTLEAF ASSET MANAGEMENT LLC | 0.00% | 0.00% | 98 | 98 | 100.00% | 1,044 | Jun 30, 2024 |
| GLOBAL RETIREMENT PARTNERS, LLC | - | - | 4 | 4 | 100.00% | 43 | Jun 30, 2024 |
Pliant Therapeutics's largest new institutional shareholder by number of shares is CHECKPOINT CAPITAL L.P., purchased 232.20K shares, valued at $2.50M, as of undefined.
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| AMERIPRISE FINANCIAL INC | - | - | - | -371,126 | -100.00% | - | Jun 30, 2024 |
| CUTTER CAPITAL MANAGEMENT, LP | - | - | - | -194,119 | -100.00% | - | Jun 30, 2024 |
| SILVERARC CAPITAL MANAGEMENT, LLC | - | - | - | -183,392 | -100.00% | - | Jun 30, 2024 |
| MARSHALL WACE, LLP | - | - | - | -130,935 | -100.00% | - | Jun 30, 2024 |
| FRED ALGER MANAGEMENT, LLC | - | - | - | -97,082 | -100.00% | - | Jun 30, 2024 |
| ATOM INVESTORS LP | - | - | - | -58,064 | -100.00% | - | Jun 30, 2024 |
| HIGHVISTA STRATEGIES LLC | - | - | - | -34,039 | -100.00% | - | Jun 30, 2024 |
| AMERICAN INTERNATIONAL GROUP, INC. | - | - | - | -28,165 | -100.00% | - | Jun 30, 2024 |
| ENTRYPOINT CAPITAL, LLC | - | - | - | -20,006 | -100.00% | - | Jun 30, 2024 |
| RATHBONES GROUP PLC | - | - | - | -11,700 | -100.00% | - | Jun 30, 2024 |
| HSBC HOLDINGS PLC | - | - | - | -10,507 | -100.00% | - | Jun 30, 2024 |
| METROPOLITAN LIFE INSURANCE CO/NY | - | - | - | -3,049 | -100.00% | - | Jun 30, 2024 |
| SIGNATUREFD, LLC | - | - | - | -417 | -100.00% | - | Jun 30, 2024 |
| TRUVESTMENTS CAPITAL LLC | - | - | - | -184 | -100.00% | - | Jun 30, 2024 |
| ALLWORTH FINANCIAL LP | - | - | - | -157 | -100.00% | - | Jun 30, 2024 |
| EVERSOURCE WEALTH ADVISORS, LLC | - | - | - | -59 | -100.00% | - | Jun 30, 2024 |
| FINANCIAL GRAVITY ASSET MANAGEMENT, INC. | - | - | - | -19 | -100.00% | - | Jun 30, 2024 |
| NELSON, VAN DENBURG & CAMPBELL WEALTH MANAGEMENT GROUP, LLC | - | - | - | -11 | -100.00% | - | Jun 30, 2024 |
| MINE & ARAO WEALTH CREATION & MANAGEMENT, LLC. | - | - | - | -2 | -100.00% | - | Jun 30, 2024 |
Pliant Therapeutics's largest sold out institutional shareholder by shares sold is AMERIPRISE FINANCIAL INC, sold -0.37M shares, valued at -, as of undefined.
Pliant Therapeutics Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| LORD ABBETT DEVELOPING GROWTH FUND, INC. | 0.81% | 748,889 | - | - | Jan 31, 2024 |
| T. Rowe Price New Horizons Fund, Inc. | 0.41% | 2,034,418 | 126,786 | 6.65% | Mar 31, 2024 |
| CORNERCAP GROUP OF FUNDS /VA/ | 0.21% | 15,170 | - | - | Sep 30, 2022 |
| PRUDENTIAL SECTOR FUNDS, INC. | 0.18% | 381,533 | - | - | Feb 29, 2024 |
| T. Rowe Price Health Sciences Fund, Inc. | 0.15% | 501,660 | -35,325 | -6.58% | Mar 31, 2024 |
| WANGER ADVISORS TRUST | 0.11% | 58,436 | - | - | Mar 31, 2024 |
| FRANKLIN STRATEGIC SERIES | 0.10% | 829,600 | 8,000 | 0.97% | Jan 31, 2024 |
| COLUMBIA ACORN TRUST | 0.10% | 310,308 | - | - | Mar 31, 2024 |
| ALGER INSTITUTIONAL FUNDS | 0.08% | 21,305 | - | - | Jan 31, 2024 |
| TEKLA LIFE SCIENCES INVESTORS | 0.07% | 35,233 | - | - | Mar 31, 2024 |
| FIDELITY MT VERNON STREET TRUST | 0.07% | 2,127,421 | -90,209 | -4.07% | Feb 29, 2024 |
| VANGUARD VALLEY FORGE FUNDS | 0.07% | 36,322 | - | - | Mar 31, 2024 |
| T. Rowe Price Quantitative Management Funds, Inc. | 0.07% | 218,131 | 10,643 | 5.13% | Mar 31, 2024 |
| ALGER PORTFOLIOS | 0.06% | 23,511 | - | - | Dec 31, 2023 |
| PRUDENTIAL JENNISON SMALL CO FUND, INC. | 0.06% | 258,082 | - | - | Mar 28, 2024 |
| FIDELITY ADVISOR SERIES VII | 0.06% | 495,259 | - | - | Jan 31, 2024 |
| ALGER FUNDS | 0.06% | 54,049 | - | - | Jan 31, 2024 |
| BlackRock Health Sciences Trust II | 0.05% | 134,378 | - | - | Mar 31, 2024 |
| PRUDENTIAL JENNISON BLEND FUND, INC. | 0.05% | 31,239 | - | - | Feb 29, 2024 |
| BlackRock Health Sciences Trust | 0.05% | 12,594 | - | - | Mar 31, 2024 |
| Humankind Benefit Corp | 0.04% | 953 | 161 | 20.33% | Dec 31, 2023 |
| Federated Hermes MDT Series | 0.03% | 77,324 | - | - | Jan 31, 2024 |
| Nuveen NASDAQ 100 Dynamic Overwrite Fund | 0.03% | 3,712 | - | - | Mar 31, 2024 |
| ALGER FUNDS II | 0.03% | 6,600 | - | - | Jan 31, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND IV | 0.03% | 75,564 | - | - | Mar 31, 2024 |
| FIDELITY DESTINY PORTFOLIOS | 0.03% | 58,000 | - | - | Mar 31, 2024 |
| VICTORY VARIABLE INSURANCE FUNDS | 0.03% | 13,350 | - | - | Mar 31, 2024 |
| SMALLCAP WORLD FUND INC | 0.02% | 1,377,327 | 464,860 | 50.95% | Mar 31, 2024 |
| FIRST TRUST EXCHANGE-TRADED ALPHADEX FUND | 0.02% | 72,652 | - | - | Jan 31, 2024 |
| T. Rowe Price Equity Series, Inc. | 0.02% | 27,537 | 5,300 | 23.83% | Mar 31, 2024 |
| QUANTITATIVE MASTER SERIES LLC | 0.02% | 100,306 | -2,716 | -2.64% | Mar 31, 2024 |
| DEUTSCHE DWS INVESTMENTS VIT FUNDS | 0.01% | 8,575 | - | - | Mar 31, 2024 |
| BlackRock Advantage SMID Cap Fund, Inc. | 0.01% | 2,415 | - | - | Mar 28, 2024 |
| FORUM FUNDS II | 0.01% | 10,800 | 1,889 | 21.20% | Mar 31, 2024 |
| VANGUARD INDEX FUNDS | 0.01% | 2,841,533 | -364,998 | -11.38% | Mar 31, 2024 |
| TIAA SEPARATE ACCOUNT VA 1 | 0.01% | 1,499 | - | - | Mar 31, 2024 |
| Nushares ETF Trust | 0.00% | 35,116 | -16,011 | -31.32% | Jan 31, 2024 |
| VICTORY PORTFOLIOS | 0.00% | 142,390 | - | - | Mar 31, 2024 |
| Destra Investment Trust | 0.00% | 7,432 | 306 | 4.29% | Mar 31, 2024 |
| VANGUARD EXPLORER FUND | 0.00% | 50,779 | - | - | Jan 31, 2024 |
| SCHWAB CAPITAL TRUST | 0.00% | 156,680 | - | - | Jan 31, 2024 |
| Fidelity Central Investment Portfolios LLC | 0.00% | 184,900 | - | - | Feb 29, 2024 |
| ALPS ETF Trust | 0.00% | 44,334 | 2,069 | 4.90% | Feb 29, 2024 |
| ETFis Series Trust I | 0.00% | 4,894 | 828 | 20.36% | Jan 31, 2024 |
| INVESCO EXCHANGE-TRADED FUND TRUST | 0.00% | 266,084 | - | - | Jan 31, 2024 |
| BNY Mellon Strategic Funds, Inc. | 0.00% | 7,132 | - | - | Mar 31, 2024 |
| FIDELITY CONCORD STREET TRUST | 0.00% | 505,880 | 17,987 | 3.69% | Feb 29, 2024 |
| Calvert Variable Products, Inc. | 0.00% | 5,614 | - | - | Mar 31, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND | 0.00% | 43,600 | - | - | Mar 31, 2024 |
| FIDELITY COVINGTON TRUST | 0.00% | 23,444 | 1,810 | 8.37% | Jan 31, 2024 |
| VANGUARD INSTITUTIONAL INDEX FUNDS | 0.00% | 38,278 | 5,508 | 16.81% | Mar 31, 2024 |
| T. Rowe Price Index Trust, Inc. | 0.00% | 26,146 | 355 | 1.38% | Mar 31, 2024 |
| Ultimus Managers Trust | 0.00% | 12,113 | - | - | Feb 29, 2024 |
| Principal Exchange-Traded Funds | 0.00% | 8,635 | - | - | Mar 31, 2024 |
| VANGUARD QUANTITATIVE FUNDS | 0.00% | 3,384 | - | - | Mar 31, 2024 |
| BNY MELLON FUNDS TRUST | 0.00% | 50,867 | - | - | Aug 31, 2023 |
| USAA MUTUAL FUNDS TRUST | 0.00% | 158,695 | 22,948 | 16.90% | Jan 31, 2024 |
| LORD ABBETT SECURITIES TRUST | 0.00% | 3,038 | - | - | Jan 31, 2024 |
| VANGUARD WORLD FUND | 0.00% | 152,490 | 11,653 | 8.27% | Feb 29, 2024 |
| Voya VARIABLE PORTFOLIOS INC | 0.00% | 19,381 | -3,627 | -15.76% | Mar 31, 2024 |
| CLEARWATER INVESTMENT TRUST | 0.00% | 5,645 | 5,645 | - | Mar 28, 2024 |
| FIDELITY SELECT PORTFOLIOS | 0.00% | 37,431 | - | - | Feb 29, 2024 |
| Global X Funds | 0.00% | 25,868 | - | - | Jan 31, 2024 |
| STATE STREET VARIABLE INSURANCE SERIES FUNDS INC | 0.00% | 2,704 | - | - | Mar 31, 2024 |
| SCHWAB STRATEGIC TRUST | 0.00% | 275,268 | 10,228 | 3.86% | Feb 29, 2024 |
| ProFunds | 0.00% | 5,296 | -1,886 | -26.26% | Mar 31, 2024 |
| BlackRock ETF Trust | 0.00% | 367 | - | - | Jan 31, 2024 |
| Dimensional ETF Trust | 0.00% | 176,137 | 120,985 | 219.37% | Jan 31, 2024 |
| VANGUARD HORIZON FUNDS | 0.00% | 9,090 | - | - | Mar 31, 2024 |
| AMERICAN CENTURY ETF TRUST | 0.00% | 42,202 | 23,954 | 131.27% | Feb 29, 2024 |
| Victory Portfolios II | 0.00% | 18,038 | - | - | Mar 31, 2024 |
| TIAA-CREF LIFE FUNDS | 0.00% | 845 | - | - | Mar 31, 2024 |
| STATE STREET INSTITUTIONAL INVESTMENT TRUST | 0.00% | 19,600 | 600 | 3.16% | Mar 31, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND II | 0.00% | 3,030 | 269 | 9.74% | Mar 31, 2024 |
| LORD ABBETT SERIES FUND INC | 0.00% | 13,912 | - | - | Mar 31, 2024 |
| Harbor ETF Trust | 0.00% | 882 | - | - | Jan 31, 2024 |
| VANGUARD VARIABLE INSURANCE FUNDS | 0.00% | 9,019 | - | - | Mar 31, 2024 |
| NORTHERN FUNDS | 0.00% | 25,041 | -280 | -1.11% | Mar 28, 2024 |
| SunAmerica Specialty Series | 0.00% | 86 | - | - | Apr 30, 2021 |
| iSHARES TRUST | 0.00% | 2,501,074 | -154,698 | -5.82% | Mar 31, 2024 |
| EQ ADVISORS TRUST | 0.00% | 157,669 | -1,059 | -0.67% | Mar 31, 2024 |
| VANGUARD SCOTTSDALE FUNDS | 0.00% | 263,245 | 35,324 | 15.50% | Feb 29, 2024 |
| RYDEX SERIES FUNDS | 0.00% | 516 | - | - | Dec 31, 2023 |
| HC CAPITAL TRUST | 0.00% | 3,964 | - | - | Mar 31, 2024 |
| RUSSELL INVESTMENT CO | 0.00% | 35,427 | -48,323 | -57.70% | Jan 31, 2024 |
| FIDELITY ADVISOR SERIES I | 0.00% | 16,400 | - | - | Feb 29, 2024 |
| VALIC Co I | 0.00% | 21,932 | 161 | 0.74% | Feb 29, 2024 |
| MASTER INVESTMENT PORTFOLIO | 0.00% | 6,701 | 4,565 | 213.72% | Mar 31, 2024 |
| PENN SERIES FUNDS INC | 0.00% | 2,000 | - | - | Mar 28, 2024 |
| NATIONWIDE VARIABLE INSURANCE TRUST | 0.00% | 9,050 | 70 | 0.78% | Mar 31, 2024 |
| FLEXSHARES TRUST | 0.00% | 5,146 | 2,890 | 128.10% | Jan 31, 2024 |
| RYDEX DYNAMIC FUNDS | 0.00% | 256 | - | - | Dec 31, 2023 |
| J.P. Morgan Exchange-Traded Fund Trust | 0.00% | 28,478 | -155 | -0.54% | Jan 31, 2024 |
| ALLSPRING MASTER TRUST | 0.00% | 3,704 | - | - | Feb 29, 2024 |
| THRIVENT SERIES FUND INC | 0.00% | 6,093 | - | - | Mar 28, 2024 |
| NATIONWIDE MUTUAL FUNDS | 0.00% | 6,903 | -672 | -8.87% | Jan 31, 2024 |
| PROSHARES TRUST | 0.00% | 12,849 | 1,738 | 15.64% | Feb 29, 2024 |
| Brighthouse Funds Trust II | 0.00% | 43,568 | - | - | Mar 31, 2024 |
| Direxion Shares ETF Trust | 0.00% | 6,661 | 383 | 6.10% | Jan 31, 2024 |
| Goldman Sachs ETF Trust | 0.00% | 4,218 | - | - | Feb 29, 2024 |
Pliant Therapeutics's largest mutual fund holder by % of total assets is "LORD ABBETT DEVELOPING GROWTH FUND, INC.", owning 748.89K shares, compromising 0.81% of its total assets.
Pliant Therapeutics Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 30 Jun, 24 | 44 | -68.79% |
| 31 Mar, 24 | 141 | - |
| 31 Dec, 23 | 141 | -1.40% |
| 30 Sep, 23 | 143 | -6.54% |
| 30 Jun, 23 | 153 | - |
| 31 Mar, 23 | 153 | 15.91% |
| 31 Dec, 22 | 132 | 15.79% |
| 30 Sep, 22 | 114 | 26.67% |
| 30 Jun, 22 | 90 | 3.45% |
| 31 Mar, 22 | 87 | 1.16% |
| 31 Dec, 21 | 86 | 10.26% |
| 30 Sep, 21 | 78 | -3.70% |
| 30 Jun, 21 | 81 | 6.58% |
| 31 Mar, 21 | 76 | 28.81% |
| 31 Dec, 20 | 59 | 11.32% |
| 30 Sep, 20 | 53 | 43.24% |
| 30 Jun, 20 | 37 | - |
As of 30 Jun 24, 44 institutions are holding Pliant Therapeutics's shares, representing a decrease of -68.79% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 30 Jun, 24 | 7,003,299 | -89.26% |
| 31 Mar, 24 | 65,187,222 | 3.95% |
| 31 Dec, 23 | 62,712,668 | 3.67% |
| 30 Sep, 23 | 60,491,672 | 3.91% |
| 30 Jun, 23 | 58,215,846 | 3.52% |
| 31 Mar, 23 | 56,237,143 | 25.80% |
| 31 Dec, 22 | 44,703,030 | -1.51% |
| 30 Sep, 22 | 45,386,469 | 50.61% |
| 30 Jun, 22 | 30,135,610 | -4.67% |
| 31 Mar, 22 | 31,613,298 | 2.47% |
| 31 Dec, 21 | 30,850,804 | 1.59% |
| 30 Sep, 21 | 30,368,211 | -1.05% |
| 30 Jun, 21 | 30,690,641 | -0.09% |
| 31 Mar, 21 | 30,719,791 | 7.73% |
| 31 Dec, 20 | 28,516,318 | 1.14% |
| 30 Sep, 20 | 28,195,469 | 3.44% |
| 30 Jun, 20 | 27,258,341 | - |
Pliant Therapeutics (PLRX) has 7.00M shares outstanding as of 30 Jun 24, down -89.26% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 30 Jun, 24 | 11.64% | 0.10% |
| 31 Mar, 24 | 108.32% | 0.95% |
| 31 Dec, 23 | 106.80% | 1.04% |
| 30 Sep, 23 | 101.35% | 1.05% |
| 30 Jun, 23 | 98.38% | 0.98% |
| 31 Mar, 23 | 100.32% | 1.19% |
| 31 Dec, 22 | 91.64% | 0.97% |
| 30 Sep, 22 | 96.98% | 1.40% |
| 30 Jun, 22 | 83.31% | 1.08% |
| 31 Mar, 22 | 87.75% | 1.20% |
| 31 Dec, 21 | 85.64% | 1.20% |
| 30 Sep, 21 | 84.58% | 1.14% |
| 30 Jun, 21 | 86.03% | 1.16% |
| 31 Mar, 21 | 86.18% | 1.34% |
| 31 Dec, 20 | 80.21% | 1.25% |
| 30 Sep, 20 | 80.15% | 1.05% |
| 30 Jun, 20 | 87.25% | - |
As of 30 Jun 24, Pliant Therapeutics is held by 11.64% institutional shareholders, representing a 0.10% growth compared to 31 Mar 24.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 24 | -62.50% |
| 31 Mar, 24 | 64 | -9.86% |
| 31 Dec, 23 | 71 | -4.05% |
| 30 Sep, 23 | 74 | -18.68% |
| 30 Jun, 23 | 91 | -8.08% |
| 31 Mar, 23 | 99 | 26.92% |
| 31 Dec, 22 | 78 | -8.24% |
| 30 Sep, 22 | 85 | 84.78% |
| 30 Jun, 22 | 46 | -6.12% |
| 31 Mar, 22 | 49 | - |
| 31 Dec, 21 | 49 | 36.11% |
| 30 Sep, 21 | 36 | -7.69% |
| 30 Jun, 21 | 39 | -20.41% |
| 31 Mar, 21 | 49 | 48.48% |
| 31 Dec, 20 | 33 | -2.94% |
| 30 Sep, 20 | 34 | -8.11% |
| 30 Jun, 20 | 37 | - |
24 institutional shareholders have increased their position in PLRX stock as of 30 Jun 24 compared to 64 in the previous quarter (a -62.50% decrease).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 8 | -78.38% |
| 31 Mar, 24 | 37 | 15.63% |
| 31 Dec, 23 | 32 | - |
| 30 Sep, 23 | 32 | -20.00% |
| 30 Jun, 23 | 40 | 33.33% |
| 31 Mar, 23 | 30 | -9.09% |
| 31 Dec, 22 | 33 | 94.12% |
| 30 Sep, 22 | 17 | -34.62% |
| 30 Jun, 22 | 26 | 23.81% |
| 31 Mar, 22 | 21 | 50.00% |
| 31 Dec, 21 | 14 | -22.22% |
| 30 Sep, 21 | 18 | -21.74% |
| 30 Jun, 21 | 23 | 76.92% |
| 31 Mar, 21 | 13 | 18.18% |
| 31 Dec, 20 | 11 | 22.22% |
| 30 Sep, 20 | 9 | - |
| 30 Jun, 20 | - | - |
8 institutional shareholders have reduced their position in PLRX stock as of 30 Jun 24 compared to 37 in the previous quarter (a -78.38% decrease).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 30 Jun, 24 | 44 | -68.79% | 7,003,299 | -89.26% | 11.64% | 0.10% | 24 | -62.50% | 8 | -78.38% |
| 31 Mar, 24 | 141 | - | 65,187,222 | 3.95% | 108.32% | 0.95% | 64 | -9.86% | 37 | 15.63% |
| 31 Dec, 23 | 141 | -1.40% | 62,712,668 | 3.67% | 106.80% | 1.04% | 71 | -4.05% | 32 | - |
| 30 Sep, 23 | 143 | -6.54% | 60,491,672 | 3.91% | 101.35% | 1.05% | 74 | -18.68% | 32 | -20.00% |
| 30 Jun, 23 | 153 | - | 58,215,846 | 3.52% | 98.38% | 0.98% | 91 | -8.08% | 40 | 33.33% |
| 31 Mar, 23 | 153 | 15.91% | 56,237,143 | 25.80% | 100.32% | 1.19% | 99 | 26.92% | 30 | -9.09% |
| 31 Dec, 22 | 132 | 15.79% | 44,703,030 | -1.51% | 91.64% | 0.97% | 78 | -8.24% | 33 | 94.12% |
| 30 Sep, 22 | 114 | 26.67% | 45,386,469 | 50.61% | 96.98% | 1.40% | 85 | 84.78% | 17 | -34.62% |
| 30 Jun, 22 | 90 | 3.45% | 30,135,610 | -4.67% | 83.31% | 1.08% | 46 | -6.12% | 26 | 23.81% |
| 31 Mar, 22 | 87 | 1.16% | 31,613,298 | 2.47% | 87.75% | 1.20% | 49 | - | 21 | 50.00% |
| 31 Dec, 21 | 86 | 10.26% | 30,850,804 | 1.59% | 85.64% | 1.20% | 49 | 36.11% | 14 | -22.22% |
| 30 Sep, 21 | 78 | -3.70% | 30,368,211 | -1.05% | 84.58% | 1.14% | 36 | -7.69% | 18 | -21.74% |
| 30 Jun, 21 | 81 | 6.58% | 30,690,641 | -0.09% | 86.03% | 1.16% | 39 | -20.41% | 23 | 76.92% |
| 31 Mar, 21 | 76 | 28.81% | 30,719,791 | 7.73% | 86.18% | 1.34% | 49 | 48.48% | 13 | 18.18% |
| 31 Dec, 20 | 59 | 11.32% | 28,516,318 | 1.14% | 80.21% | 1.25% | 33 | -2.94% | 11 | 22.22% |
| 30 Sep, 20 | 53 | 43.24% | 28,195,469 | 3.44% | 80.15% | 1.05% | 34 | -8.11% | 9 | - |
| 30 Jun, 20 | 37 | - | 27,258,341 | - | 87.25% | - | 37 | - | - | - |
Pliant Therapeutics Insider Shareholders Trades
Open Market Insider Trades
Open Market Insider Buys
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
Insider Sells
All Insider Owners Trades
The last insider sell of Pliant Therapeutics's stock was made by Lefebvre Eric on Jul 12 2024, selling 12,319 shares at $11.56 per share (valued at $142.41K).
Pliant Therapeutics Insider Ownership Trends
All Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q3 2024 | 5 | 5 | 100.00% |
| Q2 2024 | 11 | 1 | 1100.00% |
| Q1 2024 | 12 | 5 | 240.00% |
| Q3 2023 | 8 | 10 | 80.00% |
| Q2 2023 | 11 | 4 | 275.00% |
| Q1 2023 | 31 | 48 | 64.58% |
| Q4 2022 | 6 | 9 | 66.67% |
| Q3 2022 | 4 | 7 | 57.14% |
| Q2 2022 | 12 | - | - |
| Q1 2022 | 5 | - | - |
| Q3 2021 | 1 | 1 | 100.00% |
| Q2 2021 | 11 | 10 | 110.00% |
| Q1 2021 | 8 | 11 | 72.73% |
| Q4 2020 | 5 | 12 | 41.67% |
| Q2 2020 | 14 | 41 | 34.15% |
| Q1 2020 | 8 | - | - |
| Q4 2019 | - | 1 | - |
5 total buy trades, and 5 total sell trades (buy/sell ratio of 1.00%) were made by Pliant Therapeutics's insiders, as of Q3 2024.
Open Market Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q3 2024 | - | 5 | - |
| Q2 2024 | - | - | - |
| Q1 2024 | - | 5 | - |
| Q3 2023 | - | 9 | - |
| Q2 2023 | - | 2 | - |
| Q1 2023 | - | 29 | - |
| Q4 2022 | - | 7 | - |
| Q3 2022 | - | 3 | - |
| Q2 2022 | - | - | - |
| Q1 2022 | - | - | - |
| Q3 2021 | - | - | - |
| Q2 2021 | - | 8 | - |
| Q1 2021 | - | 10 | - |
| Q4 2020 | - | 8 | - |
| Q2 2020 | - | - | - |
| Q1 2020 | - | - | - |
| Q4 2019 | - | - | - |
As of Q3 2024, Insider owners conducted 0 open market buy trades and 5 open market sell trades of Pliant Therapeutics's stocks.
Pliant Therapeutics Peer Ownership
| Ticker | Company |
|---|---|
| ARVN | Arvinas, Inc. |
| DYN | Dyne Therapeutics, Inc. |
| RVMD | Revolution Medicines, Inc. Warrant |
| VRDN | Viridian Therapeutics, Inc. |
| STOK | Stoke Therapeutics, Inc. |
| BDTX | Black Diamond Therapeutics, Inc. |
| RLAY | Relay Therapeutics, Inc. |
| BCEL | Atreca, Inc. |
| SNDX | Syndax Pharmaceuticals, Inc. |
| PASG | Passage Bio, Inc. |
| INZY | Inozyme Pharma, Inc. |
| ACLX | Arcellx, Inc. |
| ETNB | 89bio, Inc. |
| CYTK | Cytokinetics, Incorporated |
| MDGL | Madrigal Pharmaceuticals, Inc. |
PLRX Ownership FAQ
Who Owns Pliant Therapeutics?
Pliant Therapeutics is owned by institutional shareholders (11.64%), insiders (2.86%), and public (85.50%). The largest institutional shareholder of Pliant Therapeutics is DEEP TRACK CAPITAL, LP (9.92% of total shares) and the top mutual fund owner is LORD ABBETT DEVELOPING GROWTH FUND, INC. (0.81% of total shares).
Who are the major institutional shareholders of Pliant Therapeutics?
Pliant Therapeutics's major institutional shareholders are DEEP TRACK CAPITAL, LP, BLACKROCK INC., PRICE T ROWE ASSOCIATES INC /MD/, FMR LLC, and VANGUARD GROUP INC. The top five shareholders own together 38.04% of the company's share outstanding.
How many Pliant Therapeutics shareholders are there?
As of Jun 2024, there are 44 institutional shareholders of Pliant Therapeutics.
What percentage of Pliant Therapeutics is owned by DEEP TRACK CAPITAL, LP?
DEEP TRACK CAPITAL, LP owns 5.97M shares of Pliant Therapeutics, representing 9.92% of the company's total shares outstanding, valued at $64.2M (as of Jun 2024).
What percentage of Pliant Therapeutics is owned by BLACKROCK INC?
As of Jun 2024, BLACKROCK INC holds 4.97M shares of Pliant Therapeutics (PLRX), compromising 8.26% of the company, valued at $53.45M.
What percentage of Pliant Therapeutics is owned by PRICE T ROWE ASSOCIATES INC /MD/?
PRICE T ROWE ASSOCIATES INC /MD/ is the third largest holder of Pliant Therapeutics. The company owns 4.6M of the company's shares outstanding (worth $49.48M).